Monday, July 22, 2019 12:05:43 PM
(See biotechnician’s post...”something of GREAT VALUE”)
This, from the Shelf Prospectus (pg 15 middle)
“Nevada Anti-Takeover Law and Charter and Bylaws Provisions
Nevada Revised Statutes sections 78.378 to 78.3793 provide state regulation over the acquisition of a controlling interest in certain Nevada corporations unless the articles of incorporation or bylaws of the corporation provide that the provisions of these sections do not apply. The statute creates a number of restrictions on the ability of a person or entity to acquire control of a Nevada company by setting down certain rules of conduct and voting restrictions in any acquisition attempt, among other things. The statute is limited to corporations that are organized in the state of Nevada and that have 200 or more shareholders, at least 100 of whom are shareholders of record and residents of the state of Nevada; and do business in the state of Nevada directly or through an affiliated corporation. Because of these conditions, the statute does not apply to our Company.
There are no provisions in our articles of incorporation or our bylaws that would delay, defer or prevent a change in control of our Company.”
The company spells out that the Nevada Statute to prevent takeover, does not apply to us.
Further,
Last sentence set off alone, for emphasis.
I asked a SEC reg filing lawyer to explain what this means. I thought the poison pill (shareholders rights plan) was put in place exactly to “slow down an unwanted change in control of the company”, by means of adding the extra warrant we would get for each share at a specified price, etc to offset a hostile maneuver. HOSTILE, key word. We are still protected from that, although, we now seem to appear less and less concerned with that eventuality, as of latest filing. Cool.
He said the wording is very interesting in this case. Normally, we would only need to answer in a Prospectus that we are incorporated in Nevada and there are Statutes which may or may not affect the takeover of our company. (Let reviewers do the work)
Likewise, we could have stated that our Articles of Incorporation provide for measures in the event of an unwanted “hostile” takeover.
(Let the reviewers read through.)
We needn’t have spelled it out to be in compliance, after all this is a public document.
We were under no obligation in a boilerplate S-3 to provide this level of detail. (Remember that our CEO is called “non-transparent to the point of being a scammer”, by some.” This is unbelievably transparent - WE ARE A SITTING DUCK!”)
We are a sitting duck - if the change in control is a DESIRED one. On favorable terms.
According to the lawyer, if they use this language, they are doing 2 things with one stone: they are providing the necessary information to the SEC - but in a publicly viewable doc which all other companies can see. Also, the language is such that, legally, if a change in control were to occur, on favorable terms, the SEC would have to review that deal before approving the necessary structure and filings to make sure there are no hitches.
Since this language will have already been viewed and approved once already by SEC, it would be pointed out again and having passed muster, they would be quicker to see - NO HITCHES.
Know anybody who likes to compress time, money, steps by preplanning the necessary language and terms to avoid confusion...? I do.
Friendly partner in the wings or Bidding war looms. Once that shelf is tapped - You will know it!
This should be the center of the “dilution” discussion.
Additionally, we were eligible to file this shelf 3 years from our uplist date, since this requires 3 years of financials. We uplisted Oct. 30, 2015. Fiscal year began Nov 1, 2015. On Nov 1, 2018, we had sufficient financial data to file. We did not, until now.
Missling knew we would need capitalization further down the road for growth. He managed the LPC/Cantor offerings and Australian discount and foundation subsidies to get us to where we are now. So, as many ask, with readouts due soon for 2 trials, why file shelf now?
“We cannot delay, deter, or prevent a change in control of our company.”
(Other interesting words in the Prospectus - it’s public! Please read.)
Partnership at worst, bidding war at best.
Looks like Someone’s Got This!
Bio
Recent AVXL News
- Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia • GlobeNewswire Inc. • 10/17/2024 11:30:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • InvestorsHub NewsWire • 10/15/2024 12:21:48 PM
- ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • InvestorsHub NewsWire • 10/01/2024 11:00:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM